434 related articles for article (PubMed ID: 24480973)
1. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma.
Melchor L; Brioli A; Wardell CP; Murison A; Potter NE; Kaiser MF; Fryer RA; Johnson DC; Begum DB; Hulkki Wilson S; Vijayaraghavan G; Titley I; Cavo M; Davies FE; Walker BA; Morgan GJ
Leukemia; 2014 Aug; 28(8):1705-15. PubMed ID: 24480973
[TBL] [Abstract][Full Text] [Related]
2. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.
Walker BA; Wardell CP; Melchor L; Hulkki S; Potter NE; Johnson DC; Fenwick K; Kozarewa I; Gonzalez D; Lord CJ; Ashworth A; Davies FE; Morgan GJ
Blood; 2012 Aug; 120(5):1077-86. PubMed ID: 22573403
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.
Egan JB; Shi CX; Tembe W; Christoforides A; Kurdoglu A; Sinari S; Middha S; Asmann Y; Schmidt J; Braggio E; Keats JJ; Fonseca R; Bergsagel PL; Craig DW; Carpten JD; Stewart AK
Blood; 2012 Aug; 120(5):1060-6. PubMed ID: 22529291
[TBL] [Abstract][Full Text] [Related]
4. Darwinian evolution and tiding clones in multiple myeloma.
Bahlis NJ
Blood; 2012 Aug; 120(5):927-8. PubMed ID: 22859708
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of clonal evolution in multiple myeloma.
Furukawa Y; Kikuchi J
Int J Hematol; 2020 Apr; 111(4):496-511. PubMed ID: 32026210
[TBL] [Abstract][Full Text] [Related]
6. [Treatment strategies for multiple myeloma based on molecular pathogenesis].
Furukawa Y
Rinsho Ketsueki; 2022; 63(9):1167-1179. PubMed ID: 36198542
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
Bolli N; Avet-Loiseau H; Wedge DC; Van Loo P; Alexandrov LB; Martincorena I; Dawson KJ; Iorio F; Nik-Zainal S; Bignell GR; Hinton JW; Li Y; Tubio JM; McLaren S; O' Meara S; Butler AP; Teague JW; Mudie L; Anderson E; Rashid N; Tai YT; Shammas MA; Sperling AS; Fulciniti M; Richardson PG; Parmigiani G; Magrangeas F; Minvielle S; Moreau P; Attal M; Facon T; Futreal PA; Anderson KC; Campbell PJ; Munshi NC
Nat Commun; 2014; 5():2997. PubMed ID: 24429703
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma clonal evolution in homogeneously treated patients.
Corre J; Cleynen A; Robiou du Pont S; Buisson L; Bolli N; Attal M; Munshi N; Avet-Loiseau H
Leukemia; 2018 Dec; 32(12):2636-2647. PubMed ID: 29895955
[TBL] [Abstract][Full Text] [Related]
9. Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH.
Yan Y; Qin X; Liu J; Fan H; Yan W; Liu L; Du C; Yu Z; Xu Y; Hao M; Deng S; Sui W; Lyu R; Liu W; Wang Q; Zou D; Hu L; Wang J; Tai YT; Anderson KC; Zhang L; Cheng T; Zetterberg A; Munshi NC; Qiu L; An G
Blood Adv; 2022 Jan; 6(2):441-451. PubMed ID: 34653241
[TBL] [Abstract][Full Text] [Related]
10. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma.
Ikeda S; Kitadate A; Abe F; Saitoh H; Michishita Y; Hatano Y; Kawabata Y; Kitabayashi A; Teshima K; Kume M; Takahashi N; Tagawa H
Cancer Sci; 2017 Apr; 108(4):641-652. PubMed ID: 28164410
[TBL] [Abstract][Full Text] [Related]
12. Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
Weinhold N; Ashby C; Rasche L; Chavan SS; Stein C; Stephens OW; Tytarenko R; Bauer MA; Meissner T; Deshpande S; Patel PH; Buzder T; Molnar G; Peterson EA; van Rhee F; Zangari M; Thanendrarajan S; Schinke C; Tian E; Epstein J; Barlogie B; Davies FE; Heuck CJ; Walker BA; Morgan GJ
Blood; 2016 Sep; 128(13):1735-44. PubMed ID: 27516441
[TBL] [Abstract][Full Text] [Related]
13. Phenotype-structured model of intra-clonal heterogeneity and drug resistance in multiple myeloma.
Bouchnita A; Volpert V
J Theor Biol; 2024 Jan; 576():111652. PubMed ID: 37952610
[TBL] [Abstract][Full Text] [Related]
14. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics.
Morita K; Wang F; Jahn K; Hu T; Tanaka T; Sasaki Y; Kuipers J; Loghavi S; Wang SA; Yan Y; Furudate K; Matthews J; Little L; Gumbs C; Zhang J; Song X; Thompson E; Patel KP; Bueso-Ramos CE; DiNardo CD; Ravandi F; Jabbour E; Andreeff M; Cortes J; Bhalla K; Garcia-Manero G; Kantarjian H; Konopleva M; Nakada D; Navin N; Beerenwinkel N; Futreal PA; Takahashi K
Nat Commun; 2020 Oct; 11(1):5327. PubMed ID: 33087716
[TBL] [Abstract][Full Text] [Related]
15. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
16. Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes.
Jacobs S; Ausema A; Zwart E; Weersing E; de Haan G; Bystrykh LV; Belderbos ME
Exp Hematol; 2020 Nov; 91():46-54. PubMed ID: 32946982
[TBL] [Abstract][Full Text] [Related]
17. Single-cell analysis based dissection of clonality in myelofibrosis.
Mylonas E; Yoshida K; Frick M; Hoyer K; Christen F; Kaeda J; Obenaus M; Noerenberg D; Hennch C; Chan W; Ochi Y; Shiraishi Y; Shiozawa Y; Zenz T; Oakes CC; Sawitzki B; Schwarz M; Bullinger L; le Coutre P; Rose-Zerilli MJJ; Ogawa S; Damm F
Nat Commun; 2020 Jan; 11(1):73. PubMed ID: 31911629
[TBL] [Abstract][Full Text] [Related]
18. Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.
Poos AM; Prokoph N; Przybilla MJ; Mallm JP; Steiger S; Seufert I; John L; Tirier SM; Bauer K; Baumann A; Rohleder J; Munawar U; Rasche L; Kortüm KM; Giesen N; Reichert P; Huhn S; Müller-Tidow C; Goldschmidt H; Stegle O; Raab MS; Rippe K; Weinhold N
Blood; 2023 Nov; 142(19):1633-1646. PubMed ID: 37390336
[TBL] [Abstract][Full Text] [Related]
19. MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib.
Xie Z; Bi C; Chooi JY; Chan ZL; Mustafa N; Chng WJ
Leukemia; 2015 Dec; 29(12):2347-54. PubMed ID: 26196464
[TBL] [Abstract][Full Text] [Related]
20. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.
Oshima K; Khiabanian H; da Silva-Almeida AC; Tzoneva G; Abate F; Ambesi-Impiombato A; Sanchez-Martin M; Carpenter Z; Penson A; Perez-Garcia A; Eckert C; Nicolas C; Balbin M; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Devidas M; Loh ML; Kirschner-Schwabe R; Palomero T; Rabadan R; Ferrando AA
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11306-11311. PubMed ID: 27655895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
